Crossmark

Not all patients benefit from the postoperative antifibrinolytic treatment: clinical evidence against the universal use of tranexamic acid following total knee arthroplasty

Crossref DOI link: https://doi.org/10.1186/s13018-022-02958-0

Published Online: 2022-01-29

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Jiacheng

Wang, Han

Wu, Xiangdong

Lei, Yiting

Huang, Wei http://orcid.org/0000-0001-9116-2985
License Information

Text and Data Mining valid from 2022-01-29

Version of Record valid from 2022-01-29
More Information

Article History

Received: 18 December 2021

Accepted: 21 January 2022

First Online: 29 January 2022

Declarations

:

: This retrospective cohort study had been approved by the ethics committee of the First Affiliated Hospital of Chongqing Medical University (2019-015) before the data analysis. There was no need for informed consent in this retrospective study.

: Not applicable.

: The authors have no relevant financial or non-financial interests to disclose.

Document is current

Any future updates will be listed below